News Industry News GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects June 04, 2019
News Daily News FDA Provides Update on Poorer Survival With Impella RP in Postmarket Setting Todd Neale May 21, 2019
News Daily News FDA Approves Dalteparin Sodium as First Anticoagulant For Use in Pediatric VTE Patients Yael L. Maxwell May 16, 2019
News Conference News HRS 2019 BeAT-HF: Baroreflex Activation Therapy Improves Outcomes in Subset of HF Patients Todd Neale May 15, 2019
News Daily News Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany Caitlin E. Cox May 14, 2019
News Industry News FDA Approves Impella 5.0 and Impella LD Extended Duration of Use to 14 Days for Cardiogenic Shock Derived from AMI or Cardiomyopathy May 13, 2019
News Industry News Rapid Medical Announces FDA Approval of Novel Temporary Aneurysm Embolization Assist Device May 07, 2019
News Daily News Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease L.A. McKeown May 06, 2019
News Daily News Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy Michael O'Riordan May 06, 2019
News Industry News Boston Scientific Receives U.S. FDA Approval for The VICI VENOUS STENT™ System May 06, 2019
News Industry News FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis May 06, 2019
News Industry News Concept Medical Inc. Granted "Breakthrough Device Designation" From FDA for Its MagicTouch Sirolimus Coated Balloon May 02, 2019
News Industry News Medtronic Receives FDA Approval for CareLink SmartSync Device Manager May 02, 2019
News Industry News FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial May 02, 2019
News Daily News Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks Todd Neale May 01, 2019
News Industry News Medtronic Receives FDA Approval for World's First Quadripolar Active Fixation Left Heart Lead May 01, 2019
News Daily News PCSK9 Inhibitor Alirocumab Receives Expanded Indication for CV Event Reduction Michael O'Riordan April 29, 2019
News Daily News FDA Approves Lotus Edge, Ushering Third Device Into US Market Shelley Wood April 24, 2019